NxGen MDx
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Michigan, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
801 Broadway Ave NW Ste 203, Grand Rapid...Phone Number
(855) 776-9436Website
www.nxgenmdx.comRevenue
$7.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About NxGen MDx
Since the company's founding in 2012, the company has continually updated the company's technologies to keep pace with advances in genetic research and screening techniques. The company's screens rely on next-generation sequencing that delivers over 99% accuracy clinical detection rates for most conditions. This powerful technique looks at entire coding regions of genes rather than the abbreviated sequencing or genotyping techniques used by other genetic screening companies. And because the company detect genetic pathogenic variants that can be missed by abbreviated screening technologies, you can count on your NxGen MDx screening results to give you a highly accurate, comprehensive assessment of your true risk and ultimately, better outcomes for you and your family.Explore more
NxGen MDx Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is NxGen MDx your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if NxGen MDx had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on NxGen MDx recently announced quarterly report
Product Launch: Get notified when NxGen MDx launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at NxGen MDx
Check if NxGen MDx has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once NxGen MDx has new funding data
Check out if NxGen MDx is spiking on competitors!
NxGen MDx, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at NxGen MDx
Find 3 more new buyers
Compare Similar Companies to NxGen MDx
Compare insights from companies similar to NxGen MDx, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
NxGen MDx is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
NxGen MDx is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about NxGen MDx.
NxGen MDx financials insights
Gather financial insights about NxGen MDx, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$1M
NxGen MDx Tech Stack
A closer look at the technologies used by NxGen MDx
See more technologies
Most Recent Scoops
Left Company
Executive Move
Eric VanderVeen, Vice President, Finance & Strategy, has recently left the organization and now serves as Chief Financial Officer for Holland Hospital.
Executive Moves, Left Company
Left Company
Executive Move
Executive Moves, Left Company
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding NxGen MDx
Sign Up For FreeTo access detailed company insights
Since the company's founding in 2012, the company has continually updated the company's technologies to keep pace with advances in genetic research and screening techniques. The company's screens rely on next-generation sequencing that delivers over 99% accuracy clinical detection rates for most conditions. This powerful technique looks at entire c... Read More
